요도 카테터 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of urinary catheter Market

The global urinary catheter market size was valued at USD 6.47 billion in 2025 and is projected to grow to USD 6.89 billion in 2026, reaching USD 11.33 billion by 2034. The market is driven by the increasing prevalence of urinary incontinence, benign prostatic hyperplasia, chronic diseases, surgical procedures, and the growing geriatric population. Europe dominated the urinary catheter market with a 42.19% market share in 2025.

Urinary catheters are flexible, hollow medical devices used to drain urine from the bladder into a collection bag or other drainage system. They are widely used in hospitals, long-term care facilities, home-care settings, and among patients requiring self-catheterization. Major product categories include intermittent, indwelling, and external catheters.

Urinary Catheter Market Trends

A major urinary catheter market trend is the development of technologically advanced catheters designed to improve patient safety and reduce complications. Catheter-associated urinary tract infections remain an important concern, encouraging manufacturers to develop antimicrobial and specialized coated catheters.

The increasing adoption of intermittent catheterization in home-care settings is another important trend. Patients are increasingly being educated about self-catheterization, particularly in developed healthcare markets. This shift supports demand for easy-to-use, patient-friendly catheter products.

Urinary Catheter Market Growth Factors

The primary urinary catheter market growth driver is the increasing prevalence of urinary incontinence. The condition affects a substantial population worldwide, with older adults representing an important patient group. Population aging is therefore expected to increase demand for urinary drainage and management products.

The increasing number of surgical procedures is another significant factor. Urinary catheters are commonly used during and after various surgeries to monitor and manage urine output. Rising healthcare expenditure and improving awareness of urinary disorders are also supporting market expansion.

However, the risk of catheter-associated urinary tract infections can restrain adoption. Manufacturers are responding through antimicrobial coatings, improved materials, and innovative catheter designs.

Urinary Catheter Market Segmentation Analysis

By Product

The market is segmented into intermittent, indwelling, and external catheters. Intermittent catheters held the largest market share, supported by their affordability, ease of use, and increasing adoption in home-care environments. Indwelling or Foley catheters remain important in hospitals and long-term care settings, while external catheters serve specific patient requirements.

By Application

The major applications include urinary incontinence, benign prostatic hyperplasia, surgery, and other conditions. The urinary incontinence segment accounted for the highest market share, supported by the growing prevalence of urinary leakage and increasing awareness of available treatment and management options.

By Gender and End User

The male segment has historically represented a major share because of urinary incontinence and BPH among male patients. By end user, the market includes hospitals, age care centers, and others, with increasing self-catheterization supporting the others segment.

Urinary Catheter Market Regional Analysis

Europe dominated the global market in 2025 and generated USD 1.08 billion. An aging population, increasing urinary disorders, and a significant number of urology and gynecology procedures support regional demand. Germany, the U.K., and France remain important European markets.

North America is expected to experience significant growth due to increasing urinary incontinence cases, surgical procedures, healthcare expenditure, and awareness regarding treatment options.

Asia Pacific is also projected to register strong growth. Rising prevalence of urinary incontinence and BPH, increasing healthcare investments, and improving awareness in countries such as China, Japan, and Australia are supporting market development. Japan is particularly influenced by its aging population and growing adoption of urinary incontinence treatment.

Competitive Landscape

Key companies operating in the urinary catheter industry include Coloplast A/S, B. Braun Melsungen AG, ConvaTec Group PLC, Amsino International, Boston Scientific Corporation, Teleflex Incorporated, Hollister Incorporated, Medtronic, BD, and Cook.

Companies are focusing on product innovation, antimicrobial technologies, expanded distribution networks, and technologically advanced catheter designs. Recent developments include Bactiguard's introduction of advanced catheter technologies and UroDev Medical's leadership expansion.

Conclusion

The urinary catheter market is projected to expand from USD 6.47 billion in 2025 to USD 6.89 billion in 2026 and reach USD 11.33 billion by 2034. Increasing urinary incontinence, population aging, BPH, rising surgical procedures, and growing adoption of self-catheterization will remain key growth factors. Intermittent catheters will maintain a leading position, while urinary incontinence will remain the major application segment. Europe will continue to represent a dominant regional market, whereas North America and Asia Pacific will provide substantial growth opportunities. Technological advances focused on infection prevention, patient comfort, and ease of use will further shape the competitive landscape through 2034.

Unit Value (USD Billion)

Segmentation By Product

• Indwelling Catheters
• Intermittent Catheters
• External Catheters

By Application

• Urinary Incontinence
• Benign Prostatic Hyperplasia
• Surgery
• Others

By Gender

• Female
• Male

By End User

• Hospitals
• Age Care Centers
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Healthcare Overview- For Key Countries
• 4.2. Disease Prevalence - Selective Diseases such as Urinary Incontinence, BPH, etc. - For Key Countries, 2025
• 4.3. Technological Developments in Urinary Catheters
• 4.4. Pricing Analysis - By Major Companies/Brands
• 4.5. Key Industry Developments - Partnerships, Mergers and Acquisitions

5. Global Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Indwelling Catheters
  • 5.2.2. Intermittent Catheters
  • 5.2.3. External Catheters
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Urinary Incontinence
  • 5.3.2. Benign Prostatic Hyperplasia
  • 5.3.3. Surgery
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Gender
  • 5.4.1. Male
  • 5.4.2. Female
• 5.5. Market Analysis, Insights and Forecast - By End User
  • 5.5.1. Hospitals
  • 5.5.2. Age Care Centers
  • 5.5.3. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Product
  • 6.2.1. Indwelling Catheters
  • 6.2.2. Intermittent Catheters
  • 6.2.3. External Catheters
• 6.3. Market Analysis - By Application
  • 6.3.1. Urinary Incontinence
  • 6.3.2. Benign Prostatic Hyperplasia
  • 6.3.3. Surgery
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Gender
  • 6.4.1. Male
  • 6.4.2. Female
• 6.5. Market Analysis, Insights and Forecast - By End User
  • 6.5.1. Hospitals
  • 6.5.2. Age Care Centers
  • 6.5.3. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Product
  • 7.2.1. Indwelling Catheters
  • 7.2.2. Intermittent Catheters
  • 7.2.3. External Catheters
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Urinary Incontinence
  • 7.3.2. Benign Prostatic Hyperplasia
  • 7.3.3. Surgery
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Gender
  • 7.4.1. Male
  • 7.4.2. Female
• 7.5. Market Analysis, Insights and Forecast - By End User
  • 7.5.1. Hospitals
  • 7.5.2. Age Care Centers
  • 7.5.3. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
  • 7.6.2. Germany
  • 7.6.3. France
  • 7.6.4. Spain
  • 7.6.5. Italy
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia pacific Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Product
  • 8.2.1. Indwelling Catheters
  • 8.2.2. Intermittent Catheters
  • 8.2.3. External Catheters
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Urinary Incontinence
  • 8.3.2. Benign Prostatic Hyperplasia
  • 8.3.3. Surgery
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Gender
  • 8.4.1. Male
  • 8.4.2. Female
• 8.5. Market Analysis, Insights and Forecast - By End User
  • 8.5.1. Hospitals
  • 8.5.2. Age Care Centers
  • 8.5.3. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Product
  • 9.2.1. Indwelling Catheters
  • 9.2.2. Intermittent Catheters
  • 9.2.3. External Catheters
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Urinary Incontinence
  • 9.3.2. Benign Prostatic Hyperplasia
  • 9.3.3. Surgery
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Gender
  • 9.4.1. Male
  • 9.4.2. Female
• 9.5. Market Analysis, Insights and Forecast - By End User
  • 9.5.1. Hospitals
  • 9.5.2. Age Care Centers
  • 9.5.3. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Urinary Catheters Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Product
  • 10.2.1. Indwelling Catheters
  • 10.2.2. Intermittent Catheters
  • 10.2.3. External Catheters
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Urinary Incontinence
  • 10.3.2. Benign Prostatic Hyperplasia
  • 10.3.3. Surgery
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Gender
  • 10.4.1. Male
  • 10.4.2. Female
• 10.5. Market Analysis, Insights and Forecast - By End User
  • 10.5.1. Hospitals
  • 10.5.2. Age Care Centers
  • 10.5.3. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC Countries
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Company Profiles
  • 11.3.1. B. Braun Melsungen AG
    • 11.3.1.1. Overview,
    • 11.3.1.2. Products & Services,
    • 11.3.1.3. SWOT Analysis,
    • 11.3.1.4. Recent Developments,
    • 11.3.1.5. Strategies,
    • 11.3.1.6. Financials (Based on Availability)
  • 11.3.2. Coloplast A/S
    • 11.3.2.1. Overview,
    • 11.3.2.2. Products & Services,
    • 11.3.2.3. SWOT Analysis,
    • 11.3.2.4. Recent Developments,
    • 11.3.2.5. Strategies,
    • 11.3.2.6. Financials (Based on Availability)
  • 11.3.3. Medtronic
    • 11.3.3.1. Overview,
    • 11.3.3.2. Products & Services,
    • 11.3.3.3. SWOT Analysis,
    • 11.3.3.4. Recent Developments,
    • 11.3.3.5. Strategies,
    • 11.3.3.6. Financials (Based on Availability)
  • 11.3.4. ConvaTec Group PLC
    • 11.3.4.1. Overview,
    • 11.3.4.2. Products & Services,
    • 11.3.4.3. SWOT Analysis,
    • 11.3.4.4. Recent Developments,
    • 11.3.4.5. Strategies,
    • 11.3.4.6. Financials (Based on Availability)
  • 11.3.5. Teleflex Incorporated
    • 11.3.5.1. Overview,
    • 11.3.5.2. Products & Services,
    • 11.3.5.3. SWOT Analysis,
    • 11.3.5.4. Recent Developments,
    • 11.3.5.5. Strategies,
    • 11.3.5.6. Financials (Based on Availability)
  • 11.3.6. Hollister Incorporated
    • 11.3.6.1. Overview,
    • 11.3.6.2. Products & Services,
    • 11.3.6.3. SWOT Analysis,
    • 11.3.6.4. Recent Developments,
    • 11.3.6.5. Strategies,
    • 11.3.6.6. Financials (Based on Availability)
  • 11.3.7. Amsino International, Inc.
    • 11.3.7.1. Overview,
    • 11.3.7.2. Products & Services,
    • 11.3.7.3. SWOT Analysis,
    • 11.3.7.4. Recent Developments,
    • 11.3.7.5. Strategies,
    • 11.3.7.6. Financials (Based on Availability)
  • 11.3.8. Boston Scientific Corporation
    • 11.3.8.1. Overview,
    • 11.3.8.2. Products & Services,
    • 11.3.8.3. SWOT Analysis,
    • 11.3.8.4. Recent Developments,
    • 11.3.8.5. Strategies,
    • 11.3.8.6. Financials (Based on Availability)
  • 11.3.9. Cook Medical
    • 11.3.9.1. Overview,
    • 11.3.9.2. Products & Services,
    • 11.3.9.3. SWOT Analysis,
    • 11.3.9.4. Recent Developments,
    • 11.3.9.5. Strategies,
    • 11.3.9.6. Financials (Based on Availability)
  • 11.3.10. Other Players
    • 11.3.10.1. Overview,
    • 11.3.10.2. Products & Services,
    • 11.3.10.3. SWOT Analysis,
    • 11.3.10.4. Recent Developments,
    • 11.3.10.5. Strategies,
    • 11.3.10.6. Financials (Based on Availability)

12. Strategic Recommendations